Concepedia
Statistics
Publications
14
Citations
646
H-Index
12
Active since
2000
Affiliations
University of Münster(Current)
Centre National de la Recherche Scientifique
Inserm
Damascus University
Saarland University
Samer Haidar is an author at University of Münster specializing in medicine, pharmacology, and drug discovery.
Top concepts
MedicinePharmacologyBiochemistryDrug DiscoveryMedicinal ChemistryBioorganic ChemistryOncologyCell BiologyEndocrinologyCancer Therapy
Publications per year
2000–2019
Preclinical Efficacy of the MDM2 Inhibitor RG7112 in <i>MDM2</i> -Amplified and <i>TP53</i> Wild-type Glioblastomas
Maïté Verreault, Charlotte Schmitt, Lauriane Goldwirt et al. · Clinical Cancer Research · 2015 · 112 citations · Full text
Drug sensitivity of single cancer cells is predicted by changes in mass accumulation rate
Mark M. Stevens, Cécile L. Maire, Nigel Chou et al. · Nature Biotechnology · 2016 · 105 citations · Full text
Single Cancer Cells, Oncology, Drug Sensitivity +10
Effects of novel 17α-hydroxylase/C17, 20-lyase (P450 17, CYP 17) inhibitors on androgen biosynthesis in vitro and in vivo
Samer Haidar, Peter B. Ehmer, Stephan Barassin et al. · The Journal of Steroid Biochemistry and Molecular Biology · 2003 · 103 citations
Biosynthesis, P450 17, Biochemistry +7
Synthesis and Evaluation of Novel Steroidal Oxime Inhibitors of P450 17 (17α-Hydroxylase/C17−20-Lyase) and 5α-Reductase Types 1 and 2
Rolf W. Hartmann, Markus Hector, Samer Haidar et al. · Journal of Medicinal Chemistry · 2000 · 84 citations · Full text
Inhibition of CYP 17, a New Strategy for the Treatment of Prostate Cancer
Rolf W. Hartmann, Peter B. Ehmer, Samer Haidar et al. · Archiv der Pharmazie · 2002 · 59 citations
Pharmacotherapy, Medicinal Chemistry, Oncology +16
1–5 of 14